Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs. | Sci Signal | 2024 | 39042728 | PubTator, text mining | PubMed |
| The method for assessing the specificity of developing CAR therapies. | Biophys Rep (N Y) | 2024 | 39025235 | PubTator, text mining | PubMed |
| mRNA-Engineered CD5-CAR-γδTCD5- Cells for the Immunotherapy of T-Cell Acute Lymphoblastic Leukemia. | Adv Sci (Weinh) | 2024 | 39013083 | PubTator, text mining | PubMed |
| Degron-Based bioPROTACs for Controlling Signaling in CAR T Cells. | ACS Synth Biol | 2024 | 38991546 | PubTator, text mining | PubMed |
| CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma. | Front Immunol | 2024 | 38979422 | PubTator, text mining | PubMed |
| Regulation of temporal cytokine production by co-stimulation receptors in TCR-T cells is lost in CAR-T cells. | Immunother Adv | 2024 | 38978751 | PubTator, text mining | PubMed |
| Novel OX40 and 4-1BB derived spacers enhance CD30 CAR activity and safety in CD30 positive lymphoma models. | Mol Ther | 2024 | 38946142 | PubTator, text mining | PubMed |
| Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. | Signal Transduct Target Ther | 2024 | 38945949 | PubTator, text mining | PubMed |
| Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells. | Mol Ther Oncol | 2024 | 38939825 | PubTator, text mining | PubMed |
| Deconstructing synthetic biology across scales: a conceptual approach for training synthetic biologists. | Nat Commun | 2024 | 38926339 | PubTator, text mining | PubMed |
| Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention. | Blood Adv | 2024 | 38889435 | PubTator, text mining | PubMed |
| Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced Exhaustion. | Cancer Immunol Res | 2024 | 38874582 | PubTator, text mining | PubMed |
| A Cysteinyl-tRNA Synthetase Mutation Causes Novel Autosomal-Dominant Inheritance of a Parkinsonism/Spinocerebellar-Ataxia Complex. | Neurosci Bull | 2024 | 38869703 | PubTator, text mining | PubMed |
| Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells. | Clin Cancer Res | 2024 | 38864848 | PubTator, text mining | PubMed |
| CAR macrophages tuning the immune symphony of anti-cancer therapies. | Cell Stem Cell | 2024 | 38848684 | PubTator, text mining | PubMed |
| Toll-like receptor 4 signaling activation domains promote CAR T cell function against solid tumors. | Mol Ther Oncol | 2024 | 38840781 | PubTator, text mining | PubMed |
| Nanoinjection: A Platform for Innovation in Ex Vivo Cell Engineering. | Acc Chem Res | 2024 | 38819691 | PubTator, text mining | PubMed |
| Genotoxicity Associated with Retroviral CAR Transduction of ATM-Deficient T Cells. | Blood Cancer Discov | 2024 | 38747501 | PubTator, text mining | PubMed |
| Expanding the role of CAR T-cell therapy: From B-cell hematological malignancies to autoimmune rheumatic diseases. | Int J Rheum Dis | 2024 | 38742463 | PubTator, text mining | PubMed |
| Stealth transgenes enable CAR-T cells to evade host immune responses. | J Immunother Cancer | 2024 | 38724463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=7